Precision assay designs engineered to support Luxembourg's burgeoning biotech ecosystem, Luxembourg Institute of Health (LIH) initiatives, and trans-border EU regulatory filings.
Luxembourg has rapidly expanded from a financial powerhouse into an elite European life sciences cluster, centered around personalized medicine, digital health, and biotechnology.
Institutions like the Luxembourg Institute of Science and Technology (LIST) and the Luxembourg Centre for Systems Biomedicine (LCSB) require high-throughput in vitro cellular validation for neurodegenerative diseases and immune profiles. Our assay services integrate directly into target screening pipelines.
Luxembourg strict adherence to the Directive 2010/63/EU requires full Replacement, Reduction, and Refinement in testing. As animal alternatives become mandatory across nutraceutical and chemical compliance, our robust in vitro toxicological modules serve as a ready-to-deploy NAM alternative.
Strategically situated within the Greater Region adjacent to France, Germany, and Belgium, Luxembourgish formulators manage tight distribution channels for botanical cosmetics, requiring rapid EC No 1223/2009 in vitro skin irritation (OECD 439) and phototoxicity assays.
Worldwide, regulatory boards—from the European Medicines Agency (EMA) to the US FDA Modernization Act 2.0—are formalizing New Approach Methodologies (NAMs). High-throughput phenotypic screening, organotypic cell cultures, and multi-endpoint enzymatic profiling are replacing long-lead animal cohorts, reducing assay turnarounds by 65% while elevating human-relevant predictability.
Luxembourgish entities regularly navigate complex health claims under EFSA (European Food Safety Authority). We empower local clients with cellular mechanistic substantiation: evaluating botanical metabolic modulators via glucose uptake assays (2-NBDG in C2C12 cells), intracellular antioxidant defense (ROS quenching via DCFH-DA), and anti-inflammatory cascades (NF-κB inhibition).
Combining vast phytochemical libraries and advanced Chinese laboratory automation with uncompromising Western scientific standards.
Backed by over 400 single-herb fingerprint profiles (HPLC, HPTLC, GC-MS), our extraction facilities isolate pure bioactives from certified origins. We bridge the raw herb sourcing bottleneck directly to microplate wells without third-party brokers.
Our state-of-the-art facility utilizes automated liquid handling systems, automated fluorescent microplate readers, and real-time kinetic viability analyzers, capable of screening tens of thousands of fractions weekly with sub-nanomolar accuracy.
Capitalizing on China's integrated reagent supply chain and highly specialized talent pool, our laboratory lowers unit testing costs by 40–60% compared to Western European CROs, while guaranteeing identical OECD-compliant data integrity.
How our analytical methodology evolves alongside Luxembourg's vision for data-driven, animal-free biomedical evaluation.
Standardized MTT/CCK-8 viability, LDH leakage, reactive oxygen species quantification, and direct cellular cytotoxicity on human primary cell lines.
Integration of human reconstructed epidermis (RhE), 3D intestinal organoids, and hepatic spheroids to mimic in vivo tissue permeability and ADME traits.
Dynamic fluid shear testing models: Gut-Liver axis chips evaluating natural phytochemical metabolism, bioavailability, and endothelial safety in real-time.
Coupling transcriptomic profiling from micro-well assays with generative computational toxicogenomics to forecast human clinical safety indices pre-trial.
Every test report, raw data file, and analytical certificate is generated strictly according to international best practices.
All toxicology procedures follow validated standards: OECD 431/439 (Skin Corrosion/Irritation), OECD 437/492 (Eye Damage), OECD 487 (In Vitro Micronucleus Test), and OECD 442C/E (Skin Sensitization).
Operating under Luxembourg and EU standard contractual clauses (SCC), all proprietary botanical fractions, proprietary formulations, and screening data are stored on isolated, encrypted servers with strict confidentiality protocols.
Temperature-controlled, cold-chain sample logistics connecting our Changsha laboratories with Luxembourg Findel Airport (LUX) via express biological courier lines, ensuring sample integrity within 72 hours.
Common inquiries from European supply heads, lead investigators, and regulatory officers.
Full-lifecycle pipeline development: from plant compound isolation to clinical research and finished dosage contract supply.
Connect with our senior scientific project managers to review assay protocols, discuss target cell lines, and secure a comprehensive quotation within 24 hours.
Send Inquiry Now